Treatment and Vaccine Development of Mycoplasma Pneumoniae

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Azithromycin; Doxycycline

Criteria

Inclusion Criteria:

• Children aged 0-18 years, admitted due to lower respiratory tract infections. Mycoplamsa pneumonia is diagnosed.

• The diagnosis is made within 72 hours after fever onset.

• The patient and his/her guardians are willing to participate the study and able to follow the instruction.

Exclusion Criteria:

• None